Giuseppe Viale Selected Research

Giuseppe Viale Research Topics

Disease

223	Breast Neoplasms (Breast Cancer) 02/2024 - 04/2002
209	Neoplasms (Cancer) 04/2024 - 04/2002
28	Neoplasm Metastasis (Metastasis) 11/2022 - 02/2005
19	Carcinoma (Carcinomatosis) 01/2018 - 05/2002
16	Triple Negative Breast Neoplasms 12/2023 - 09/2008
12	Noninfiltrating Intraductal Carcinoma (DCIS) 04/2024 - 03/2003
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 12/2004
8	Pathologic Complete Response 02/2024 - 08/2014
8	Melanoma (Melanoma, Malignant) 02/2023 - 10/2009
6	Lung Neoplasms (Lung Cancer) 01/2019 - 06/2004
5	Disease Progression 06/2021 - 03/2004
5	Ductal Carcinoma 09/2015 - 07/2009
5	Adenocarcinoma 05/2012 - 10/2005
5	Small Cell Carcinoma 04/2011 - 11/2003
5	Carcinoid Tumor (Carcinoid) 10/2010 - 11/2003
4	Residual Neoplasm 02/2024 - 01/2010
4	Carcinogenesis 01/2020 - 10/2002
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2017 - 10/2002
4	Lymphatic Metastasis 08/2014 - 11/2003
3	Colonic Neoplasms (Colon Cancer) 01/2023 - 01/2016
3	Adenocarcinoma of Lung 01/2021 - 03/2014
3	Hypertension (High Blood Pressure) 01/2018 - 03/2009
3	Ovarian Neoplasms (Ovarian Cancer) 09/2016 - 10/2006
3	Lobular Carcinoma 09/2015 - 10/2009
3	Lymphoma (Lymphomas) 10/2011 - 08/2003
3	Sarcoma (Soft Tissue Sarcoma) 04/2011 - 05/2004

Drug/Important Bio-Agent (IBA)

62	Estrogen ReceptorsIBA 11/2023 - 04/2002
60	Hormones (Hormone)IBA 04/2024 - 05/2003
40	Biomarkers (Surrogate Marker)IBA 01/2024 - 09/2002
37	Progesterone Receptors (Progesterone Receptor)IBA 01/2023 - 05/2002
33	human ERBB2 proteinIBA 11/2023 - 12/2005
29	Proteins (Proteins, Gene)FDA Link 02/2024 - 04/2003
28	Trastuzumab (Herceptin)FDA Link 09/2022 - 07/2008
26	Tamoxifen FDA LinkGeneric 06/2023 - 06/2003
24	Phenobarbital (Luminal)FDA Link 02/2024 - 12/2010
20	Estrogens (Estrogen)FDA Link 01/2022 - 09/2004
20	Letrozole (Femara)FDA LinkGeneric 01/2021 - 09/2007
18	ErbB Receptors (EGF Receptor)IBA 06/2023 - 12/2004
15	ParaffinIBA 12/2023 - 07/2012
14	Formaldehyde (Formol)FDA Link 12/2023 - 07/2012
13	Fluorouracil (Carac)FDA LinkGeneric 08/2015 - 04/2003
11	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 06/2010
10	RNA (Ribonucleic Acid)IBA 04/2024 - 02/2010
10	Messenger RNA (mRNA)IBA 02/2024 - 10/2002
10	Cisplatin (Platino)FDA LinkGeneric 08/2015 - 11/2006
9	pertuzumabIBA 02/2024 - 07/2017
9	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2023 - 04/2003
8	SteroidsIBA 01/2024 - 10/2004
8	Aromatase InhibitorsIBA 06/2023 - 07/2014
7	exemestane (Aromasin)FDA Link 01/2024 - 07/2014
7	Methotrexate (Mexate)FDA LinkGeneric 12/2023 - 04/2003
7	AnthracyclinesIBA 12/2021 - 05/2008
7	Progesterone FDA LinkGeneric 08/2015 - 07/2006
6	AntibodiesIBA 02/2024 - 09/2002
6	Immune Checkpoint InhibitorsIBA 09/2023 - 10/2016
6	Cadherins (E-Cadherin)IBA 01/2020 - 11/2003
6	Monoclonal AntibodiesIBA 01/2018 - 11/2003
6	fascinIBA 04/2007 - 05/2003
5	B7-H1 AntigenIBA 01/2022 - 12/2017
5	Docetaxel (Taxotere)FDA Link 10/2020 - 02/2010
5	Lapatinib (GW572016)FDA Link 08/2019 - 10/2008
5	Cyclin D1IBA 01/2018 - 01/2005
5	Epirubicin (Ellence)FDA LinkGeneric 08/2015 - 11/2006
5	Vinorelbine (Navelbine)FDA LinkGeneric 06/2015 - 07/2008
4	Ado-Trastuzumab EmtansineIBA 02/2024 - 10/2021
4	Immunoconjugates (Immunoconjugate)IBA 01/2023 - 09/2022
4	liposomal doxorubicin (Doxil)FDA Link 12/2021 - 12/2010
4	Paclitaxel (Taxol)FDA LinkGeneric 11/2021 - 09/2008
4	Capecitabine (Xeloda)FDA Link 10/2020 - 12/2008
4	Protein Isoforms (Isoforms)IBA 08/2015 - 07/2005
4	Cyclin D3IBA 01/2005 - 08/2003
3	Estradiol (Delestrogen)FDA LinkGeneric 01/2024 - 10/2015
3	Phosphotransferases (Kinase)IBA 06/2023 - 08/2006
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2022 - 06/2004
3	130-nm albumin-bound paclitaxelIBA 01/2022 - 01/2020
3	atezolizumabIBA 01/2022 - 01/2020
3	MicroRNAs (MicroRNA)IBA 06/2021 - 02/2015
3	AndrogensIBA 06/2021 - 07/2006
3	taxaneIBA 01/2020 - 03/2009
3	Triptorelin Pamoate (Trelstar)FDA Link 10/2019 - 04/2010
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 10/2019 - 02/2007
3	Hematoxylin (Haematoxylon)IBA 09/2017 - 02/2005
3	Eosine Yellowish-(YS) (Eosin)IBA 09/2017 - 02/2005
3	Ki-67 Antigen (Ki 67 Antigen)IBA 02/2016 - 09/2003
3	Bevacizumab (Avastin)FDA Link 06/2015 - 03/2009
3	Alkylating AgentsIBA 08/2014 - 06/2010
3	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2013 - 12/2010
3	VimentinIBA 06/2011 - 09/2003
3	SynaptophysinIBA 04/2011 - 05/2003

Therapy/Procedure

121	Therapeutics 02/2024 - 04/2002
61	Drug Therapy (Chemotherapy) 12/2023 - 04/2003
19	Neoadjuvant Therapy 11/2022 - 11/2004
18	Adjuvant Chemotherapy 01/2023 - 04/2003
12	Immunotherapy 09/2023 - 11/2017
9	Segmental Mastectomy (Lumpectomy) 01/2021 - 03/2004
9	Radiotherapy 01/2021 - 03/2004
7	Lymph Node Excision (Lymph Node Dissection) 10/2021 - 01/2005
7	Mastectomy (Mammectomy) 01/2021 - 03/2003
4	Aftercare (After-Treatment) 09/2015 - 06/2003
3	Operative Surgical Procedures 10/2015 - 02/2004